Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relestat split-face study in mild-to-moderate rosacea
TCTR20260905003Phase 2Recruiting
- Sponsor
- Dermatological Society of Thailand
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epinastine in rosacea, sponsored by Dermatological Society of Thailand. Started Aug 2026; status: recruiting.
02
Drugs
epinastine
03
Conditions
rosacea
Beyond the preview
Go deeper on TCTR20260905003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260905003.